Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

LE did not state ¨that they were receiving some attractive scenarios out of the nearly 20 CDAs with others under review,.....¨.

The foowing quote by LE was in the 1/16/18 pr:“Datasets now in hand, reflecting three successfully completed Phase 2 studies across which multiple endpoints were met, have brought the Company to an important inflection point regarding Brilacidin. In coming weeks, we look forward to advancing these discussions with attractive partnership / licensing scenarios, ¨

As noted previously, ¨in coming weeks¨ has become months. What is his definition of coming weeks? 2,4,8,16,32,64,128,256,etc..?

I suppose the Clinical Study Report, along with compiling the Briefing Package, and meeting with the FDA will happen in the ¨coming weeks¨.